Refine by
Myocardial Infarction Suppliers & Manufacturers
54 companies found
based inShipley, UNITED KINGDOM
Our founders have more than 50 years of experience in the field of protein and antibody research. They are experts in this niche market and the main purpose behind the creation of this company was to offer customers with the highest quality ...
based inMulhouse, FRANCE
CellProthera is a biotech company, incorporated in April 2008, and intended for the development, registration and marketing of innovative therapeutic solutions for the regeneration of organs damaged by disease or trauma from autologous blood ...
based inKiel, GERMANY
tiakis biotech AG (“tiakis”) – formerly Proteo Biotech AG - is the next generation preventive therapeutic technology company. We focus on our clinical-stage proprietary and pioneering tissue protective drug ...
based inNew York, NEW YORK (USA)
PMcardio by Powerful Medical is an AI-powered ECG interpretation tool designed to diagnose up to 49 heart conditions, including critical hidden heart attacks. It covers a wide range of diagnoses such as various heart rhythms (e.g., sinus ...
Designed for both individual and organizational use, PMcardio offers precise AI-driven interpretations of ECG data to aid in the timely diagnosis of various cardiac conditions. Key functionalities include the detection of acute ST-elevation ...
based inHechingen, GERMANY
Founded in 2000 in Germany, Translumina is a global interventional cardiovascular devices company with an ambition to deliver world-class products and services. We are a fully integrated product development and manufacturing company with ...
The Translumina Yukon drug-eluting stent product family, coated with Rapamycin (Sirolimus) and the biodegradable component polylactide (PLA), has an excellent history of pre-clinical and long-term clinical ...
based inBangkok, THAILAND
The Regeneration Center provides comprehensive and scientifically backed stem cell treatments for numerous conditions and degenerative diseases. Through years of research and clinical applications of modern cellular therapeutics our internationally ...
based inPoway, CALIFORNIA (USA)
THERMOPEUTIX, INC. is a San Diego-based privately held company that offers imaginative, innovative and economical solutions to unmet medical needs. The medical specialties that are currently targeted include interventional cardiology and radiology, ...
Rapid, selective, deep cooling of the brain (cerebral hypothermia). Numerous studies have proven the potential for hypothermia to protect the brain where lack of oxygen threatens to destroy brain tissue. The unique design of TwinFlo™ ...
based inGangwon-do, SOUTH KOREA
Boditech Med has been established as an antibody developing and manufacturing business in 1998. We’ve changed our business direction to in-vitro diagnostic market in 2000 considering potential of the market segment. Since then, we have reached ...
Tn-I, CK-MB, and Myoglobin are secreted in blood after the heart gets injured by cardiac stress for the lack of oxygen. The levels of these biomarkers can reveal the degree of a heart attack or damage. It would test for the level of those biomarkers ...
based inYongin, SOUTH KOREA
Bilix is established based on the world’s first PEGylated bilirubin platform technology to produce numerous “First in Class” in anti-inflammatory and “Best in Class” in cancer therapy drugs in addition to achieving other business platform such as ...
Many inflammatory diseases are associated with reactive oxygen species(ROS) in the body. The bilirubin nanoparticle has strong antioxidant, ROS scavenging, and immune modulating properties which effectively eliminate the disease-causing ...
based inBrønshøj, DENMARK
For health care professionals working with critically ill patients, life isn’t a given—it’s the ultimate goal. They face demanding, heartbreaking and rewarding situations every day. Their goal is to improve patient care. Our goal is to help them. We ...
based inStaten Island, NEW YORK (USA)
The SensitivE Audit is a health level assessment device that can detect diseases at the early stages, when there are no florid symptoms, and offers the highest accuracy of up to 97%. Thanks to the joint work of physicists, physicians and computer ...
The work of the TempoHeort module is based on the method of scoring the heart rate vegetative regulation. Analyzing the heart rate variability one can determine the total activity of regulatory mechanisms, the relationship between the sympathetic ...
based inEncino, CALIFORNIA (USA)
Since 1986, Jant Pharmacal has supplied U.S. and international lab and diagnostic practice settings with Point of Care (POC) diagnostic tests, laboratory instrumentation, reagents and consumables. Our highly trained staff’s key focus is on our ...
The RAMP® NT-proBNP test is an accurate, quantitative and rapid diagnostic test that aids in the diagnosis and assessment of severity in individuals suspected of having congestive heart failure (CHF) and can aid in the risk stratification of ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
UCL-TRO-1938 is a potent small molecule allosteric activator of PI3Kα with an EC50 value of approximately 60 μM. UCL-TRO-1938 can induce cell proliferation and has cardioprotective effects from ischaemia reperfusion injury and enhances nerve ...
based inDiepenbeek, BELGIUM
Founded in 2012, InnoSer is an innovative and dynamic contract research organization supporting preclinical development of drugs from its facilities in Belgium and the Netherlands. InnoSer supports its customers in the critical steps of their drug ...
based inFrankfurt am Main, GERMANY
We are leaders in therapeutic target discovery and RNA-targeted therapies in cardiovascular and cardiometabolic disease. Our technology platforms seamlessly integrate synergistically to accelerate development of RNAi therapies to treat illnesses ...
Loss of cardiomyocytes (heart cells) is the primary hallmark of heart failure. However, unlike other cell types, there is a limited capacity for cardiomyocytes proliferation in the adult heart and in the failing human heart. Therefore, regenerative ...
based inDaresbury, UNITED KINGDOM
Point of Care (PoC) medical diagnostics is a $ multi-billion global market. Driven by patient need for self monitoring and healthcare cost savings, hand-held devices or readers offering rapid diagnostic test results are fast replacing often slow and ...
Bio-AMD’s planned Generic PoC Magnetic Immunoassay Detection System (‘MIDS’), is expected to have a significantly enhanced sensitivity based on magnetic nano-particle manipulation and detection, capable of interpreting results on a ...
based inCleveland, OHIO (USA)
TecTraum Inc. has designed and developed the world’s first-ever medical device treatment for concussions, potentially reducing the effects of brain injury. Designated by the U.S. Food and Drug Administration as a Breakthrough Device, pro2cool offers ...
based inLeeds, UNITED KINGDOM
Founded in 2009, Leeds-based Arterius is developing a next-generation bioresorbable cardiovascular scaffold (stent) with an emerging market-leading clinical profile. The founding directors have significant experience in the development of medical ...
based inBelfast, UNITED KINGDOM
Biopanda Reagents develops and manufactures in vitro test kits for clinical laboratories, veterinary practice, environmental protection, and food safety, both locally and globally. Our company provides innovative, high quality and cost-effective ...
This Point-of-Care rapid test, is a rapid chromatographic immunoassay, for the qualitative detection of human H-FABP in whole blood (venipuncture or fingerstick blood), serum, or plasma samples. Results are available in 10 minutes, to assist health ...
based inVienna, AUSTRIA
Aposcience AG is a worldwide innovation leader in the field of regenerative medicine. Regenerative medicine has the potential to transform the treatment for diseases with high medical need, as the tissues afflicted by the disease process can be ...
The company's systemic formulation (APO-1 (APOSECTM)) derived from peripheral white blood cells (PBMCs) has been evaluated in animal models of wound healing, stroke, spinal cord injury, and models of chronic and acute myocardial ...